Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage.

Rebleeding is an important cause of death and disability in people with aneurysmal subarachnoid haemorrhage. Rebleeding is probably due to dissolution of the clot by natural fibrinolytic activity.